Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR MODULATION OF MILCK1
Document Type and Number:
WIPO Patent Application WO/2021/142217
Kind Code:
A1
Abstract:
Aspects of the disclosure relate to molecular payloads that modulate the expression or activity of MLCK1 and complexes comprising a muscle-targeting agent covalently linked to the molecular payloads. In some embodiments, the muscle-targeting agent specifically binds to an internalizing cell surface receptor on a muscle cell (e.g., a smooth muscle cell). In some embodiments, the molecular payload is an oligonucleotide, such as an antisense oligonucleotide or RNAi oligonucleotide.

Inventors:
SUBRAMANIAN ROMESH R (US)
QATANANI MOHAMMED T (US)
WEEDEN TIMOTHY (US)
DESJARDINS CODY A (US)
QUINN BRENDAN (US)
Application Number:
PCT/US2021/012637
Publication Date:
July 15, 2021
Filing Date:
January 08, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
DYNE THEREAPEUTICS INC (US)
International Classes:
A61K31/7088; A61K31/7105; A61K39/395; A61K47/66; A61K47/68; C07K16/28
Domestic Patent References:
WO2020028842A12020-02-06
WO2020028861A12020-02-06
Foreign References:
US20190298847A12019-10-03
US20130084261A12013-04-04
US20100260773A12010-10-14
Attorney, Agent or Firm:
GE, Zhiyun et al. (US)
Download PDF: